The adverse association found in this study between hyperglycemia and breast cancer-specific mortality is substantiated by current literature that hyperglycemia may promote tumor cell proliferation, invasion, and migration through various pathways, including the “Warburg” effect resulting in increased glucose consumption by cancer cells, activation of epidermal growth factor and insulin receptors, and production of pro-inflammatory factors. This evidence concerns the gene INSR and breast cancer.